Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy
Abroad (travel likely)Recruiting
Conditions
Drug Resistant Epilepsy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The Mater, South Brisbane, Queensland, Australia
Contact: Principal Investigator (Donald Craig)The Alfred Hospital, Melbourne, Victoria, Australia
Contact: Principal Investigator (Hugh Simpson, MD)
Study leads
Terence O'Brien, MD
Study Chair
The Alfred Hospital and Monash University